Aptar CSP Technologies: Fully Integrated Active Packaging System Combining Moisture Adsorption and Oxygen Scavenging Properties

Oxygen scavenging and moisture adsorption system added to Aptar CSP Technologies’ 3-phase Activ-Polymer platform technology portfolio.

3-phase Activ-Polymer platform technology is made to offer customized active packaging systems designed to meet the drug developer’s specific formulation as well as provide a broad spectrum of drug-specific protection.
3-phase Activ-Polymer platform technology is made to offer customized active packaging systems designed to meet the drug developer’s specific formulation as well as provide a broad spectrum of drug-specific protection.

Aptar CSP Technologiesa provider of material science and active packaging systems designed to ensure product protection, extended shelf life, and improved user experiences, and part of AptarGroup, Inc.—announces the launch of its combination oxygen scavenging and moisture adsorption active packaging system. This technology is meant to utilize the company’s patented 3-phase Activ-Polymer platform within its Activ-Film product configuration.

This combination technology has been created to build on the recent U.S. FDA approval of an HIV prevention medicine expected to launch in Q1 2020 that utilizes the company’s Activ-Blister packaging system which is meant to provide moisture adsorption and drug product stability.

Aptar CSP Technologies added the combined oxygen scavenging and moisture adsorption capability to the Activ-Film product to provide customers with a fully integrated system for drug products that are sensitive to both moisture and oxidation. The technology’s proprietary formulation is designed to provide dual protection in various packaging configurations, such as Activ-Blister, and broad application fields ranging from oral solid dose and transdermal to diagnostics and probiotics.

“This is an important milestone for Aptar CSP as we continue to expand the capabilities of our 3-phase Activ-Polymer platform technology to accelerate and de-risk the product development process, providing solutions that improve and save patients’ lives,” says Badre Hammond, vice president Commercial Operations, Aptar CSP Technologies. “This technology can help reduce packaging complexity while providing a custom solution to stability concerns, enabling pharmaceutical companies to enhance drug stability and support speed-to-market.”

Aptar CSP Technologies’ 3-phase Activ-Polymer platform technology is made to offer customized active packaging systems designed to meet the drug developer’s specific formulation as well as provide a broad spectrum of drug-specific protection, including aroma emitting, volatile organic compounds (VOCs) scavenging, and anti-microbial scavenging.

 

 

Companies in this article
More in Package design